Velcade and high-dose melphalan: a new preparative regimen before autologous stem cell transplantation for multiple myeloma

被引：0
|
作者：
Danho, C [1 ]
Huynh, A [1 ]
Roussel, M [1 ]
Ysebaert, L [1 ]
Recher, C [1 ]
Huguet, FR [1 ]
Nouvel, C [1 ]
Laurent, G [1 ]
Attal, M [1 ]
机构：
[1] CHU Purpan, Toulouse, France
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S137 / S137
页数：1
相关论文
共 50 条
  • [41] Microbiota dysbiosis after high-dose melphalan and autologous hematopoietic cell transplantation in multiple myeloma
    Malard, Florent
    Battipaglia, Giorgia
    Gaugler, Beatrice
    Siblany, Lama
    van de Wyngaert, Zoe
    Bonnin, Agnes
    Dulery, Remy
    Banet, Anne
    Stocker, Nicolas
    Ricard, Laure
    Brissot, Eolia
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2023, 58 (11) : 1275 - 1278
  • [42] High-dose melphalan and etoposide prior to autologous hematopoietic stem cell transplant is an effective regimen in the treatment of multiple myeloma.
    Briggs, AD
    Taylor, CW
    Sturm, TJ
    Shapiro, TW
    List, AF
    BLOOD, 1998, 92 (10) : 362B - 362B
  • [43] Microbiota dysbiosis after high-dose melphalan and autologous hematopoietic cell transplantation in multiple myeloma
    Florent Malard
    Giorgia Battipaglia
    Béatrice Gaugler
    Lama Siblany
    Zoe van de Wyngaert
    Agnes Bonnin
    Rémy Duléry
    Anne Banet
    Nicolas Stocker
    Laure Ricard
    Eolia Brissot
    Mohamad Mohty
    Bone Marrow Transplantation, 2023, 58 : 1275 - 1278
  • [44] Addition of bortezomib (Velcade™) to high dose melphalan (Vel-Mel) as an effective conditioning regimen with autologous stem cell support in multiple myeloma (MM).
    Hollmig, K
    Stover, J
    Talamo, G
    Zangari, M
    Thertulien, R
    van Rhee, F
    Fassas, A
    Anaissie, E
    Tricot, G
    Barlogie, B
    BLOOD, 2004, 104 (11) : 266A - 266A
  • [45] Arsenic trioxide with ascorbic acid and high-dose melphalan for autologous hematopoietic stem cell transplantation for multiple myeloma.
    Qazilbash, Muzaffar H.
    Saliba, Rima M.
    Davis, Marilyn S.
    Mendoza, Floralyn L.
    Hosing, Chitra
    Couriel, Daniel R.
    De Lima, Marcos
    Kebriaei, Partow
    Weber, Donna M.
    Wang, Michael
    Alousi, Arnin M.
    Matthes, Steven G.
    Jones, Roy B.
    Champlin, Richard E.
    Giralt, Sergio A.
    BLOOD, 2006, 108 (11) : 881A - 881A
  • [46] Phagocyte function decreases after high-dose treatment with melphalan and autologous stem cell transplantation in patients with multiple myeloma
    Wichert, Stina
    Pettersson, Asa
    Hellmark, Thomas
    Johansson, Asa
    Hansson, Markus
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (05) : 342 - 351
  • [47] Role of High-Dose Melphalan and Autologous Stem Cell Transplantation in Multiple Myeloma Patients Presenting with t(11;14)
    Sobejano, Eduardo
    De La Calle, Veronica Gonzalez
    Higuero, Victor
    Escalante, Fernando
    Garcia-Sanz, Ramon
    Presa, Daniel
    Azibeiro, Raul
    Fonseca, Marta
    Rey, Beatriz
    Puig, Noemi
    Gutierrez, Norma C.
    Leoz, Pilar
    Labrador, Jorge
    Aguilera, Carmen
    Alonso, Jose Maria Alonso
    Lopez, Rosa
    Mateo, Aranzazu Garcia
    Garcia, Alfonso
    Hernandez, Roberto
    Garcia, Abelardo Barez
    Davila, Julio
    Redondo, Elena
    Quiros, Victor
    Mateos, Maria-Victoria
    BLOOD, 2019, 134
  • [48] Melphalan Dose Intensity for Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma
    Srour, Samer A.
    Milton, Denai
    Bashir, Qaiser
    Mehta, Rohtesh S.
    Delgado, Ruby
    Rondon, Gabriela
    Nieto, Yago
    Hosing, Chitra M.
    Popat, Uday R.
    Ciurea, Stefan O.
    Patel, Krina
    Lee, Hans C.
    Manasanch, Elisabet
    Thomas, Sheeba
    Weber, Donna
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [49] High-dose idarubicine, busulphan and melphalan for autologous stem cell transplantation in multiple myeloma. Comparison with an historical control
    Capria, S
    Ribersani, M
    Ferrazza, G
    Micozzi, A
    Petrucci, MT
    Simone, F
    Torromeo, MC
    Trisolini, SM
    Mandelli, F
    Meloni, G
    BONE MARROW TRANSPLANTATION, 2003, 31 : S81 - S82
  • [50] Multiple myeloma preparative regimens for high-dose therapy and autologous transplantation: what's new?
    Aljitawi, Omar S.
    McGuirk, Joseph P.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2012, 1 (01) : 57 - 70
12345